Works by Maurer, Gabriele

Results: 22

Matching Quantitative MRI Parameters with Histological Features of Treatment-Naïve IDH Wild-Type Glioma.

Published in:

Cancers, 2021, v. 13, n. 16, p. 4060, doi. 10.3390/cancers13164060

By:

Maurer, Gabriele D.;
Tichy, Julia;
Harter, Patrick N.;
Nöth, Ulrike;
Weise, Lutz;
Quick-Weller, Johanna;
Deichmann, Ralf;
Steinbach, Joachim P.;
Bähr, Oliver;
Hattingen, Elke

Publication type:

Article

Cetuximab-Mediated Protection from Hypoxia- Induced Cell Death: Implications for Therapy Sequence in Colorectal Cancer.

Published in:

Cancers, 2020, v. 12, n. 10, p. 3050, doi. 10.3390/cancers12103050

By:

Urban, Hans;
Maurer, Gabriele D.;
Luger, Anna-Luisa;
Lorenz, Nadja I.;
Sauer, Benedikt;
Stroh, Christopher;
Trojan, Jörg;
Mittelbronn, Michel;
Steinbach, Joachim P.;
Harter, Patrick N.;
Ronellenfitsch, Michael W.

Publication type:

Article

Influence of pregnancy on glioma patients.

Published in:

Acta Neurochirurgica, 2019, v. 161, n. 3, p. 535, doi. 10.1007/s00701-019-03823-6

By:

Forster, Marie-Therese;
Baumgarten, Peter;
Gessler, Florian;
Maurer, Gabriele;
Senft, Christian;
Hattingen, Elke;
Seifert, Volker;
Harter, Patrick N.;
Franz, Kea

Publication type:

Article

FOXO3a orchestrates glioma cell responses to starvation conditions and promotes hypoxia-induced cell death.

Published in:

International Journal of Oncology, 2016, v. 49, n. 6, p. 2399, doi. 10.3892/ijo.2016.3760

By:

BRUCKER, DANIEL P.;
MAURER, GABRIELE D.;
HARTER, PATRICK N.;
RIEGER, JOHANNES;
STEINBACH, JOACHIM P.

Publication type:

Article

ERGO: A pilot study of ketogenic diet in recurrent glioblastoma.

Published in:

International Journal of Oncology, 2014, v. 44, n. 6, p. 1843, doi. 10.3892/ijo.2014.2382

By:

RIEGER, JOHANNES;
BÄHR, OLIVER;
MAURER, GABRIELE D.;
HATTINGEN, ELKE;
FRANZ, KEA;
BRUCKER, DANIEL;
WALENTA, STEFAN;
KÄMMERER, ULRIKE;
COY, JOHANNES F.;
WELLER, MICHAEL;
STEINBACH, JOACHIM P.

Publication type:

Article

Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST study.

Published in:

European Stroke Journal, 2024, v. 9, n. 3, p. 696, doi. 10.1177/23969873241242239

By:

Diener, Hans-Christoph;
Grosse, Gerrit M;
Hüsing, Anika;
Stang, Andreas;
Kuklik, Nils;
Brinkmann, Marcus;
Maurer, Gabriele D;
Soda, Hassan;
Pohlmann, Carsten;
Hilker-Roggendorf, Rüdiger;
Popovic, Nikola;
Kraft, Peter;
Mackert, Bruno-Marcel;
Eschenfelder, Christoph C;
Weimar, Christian

Publication type:

Article

Real-Time Monitoring in der Psychotherapie -- Methodik und Kasuistik.

Published in:

Neuropsychiatrie, 2011, v. 25, n. 3, p. 135

By:

Maurer, Gabriele;
Aichhorn, Wolfgang;
Leeb, Wilfried;
Matschi, Brigitte;
Schiepek, Günter

Publication type:

Article

Integrin control of the transforming growth factor-[beta] pathway in glioblastoma.

Published in:

2013

By:

Roth, Patrick;
Silginer, Manuela;
Goodman, Simon L;
Hasenbach, Kathy;
Thies, Svenja;
Maurer, Gabriele;
Schraml, Peter;
Tabatabai, Ghazaleh;
Moch, Holger;
Tritschler, Isabel;
Weller, Michael

Publication type:

Journal Article

Integrin control of the transforming growth factor-β pathway in glioblastoma.

Published in:

Brain: A Journal of Neurology, 2013, v. 136, n. 2, p. 564, doi. 10.1093/brain/aws351

By:

Roth, Patrick;
Silginer, Manuela;
Goodman, Simon L.;
Hasenbach, Kathy;
Thies, Svenja;
Maurer, Gabriele;
Schraml, Peter;
Tabatabai, Ghazaleh;
Moch, Holger;
Tritschler, Isabel;
Weller, Michael

Publication type:

Article

18F-FET PET imaging in differentiating glioma progression from treatment-related changes – a single-center experience.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.234757

By:

Maurer, Gabriele D.;
Brucker, Daniel P.;
Stoffels, Gabriele;
Filipski, Katharina;
Filss, Christian P.;
Mottaghy, Felix M.;
Galldiks, Norbert;
Steinbach, Joachim P.;
Hattingen, Elke;
Langen, Karl-Josef

Publication type:

Article

Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression.

Published in:

Journal of Neuro-Oncology, 2022, v. 159, n. 3, p. 519, doi. 10.1007/s11060-022-04089-2

By:

Müller, Marguerite;
Winz, Oliver;
Gutsche, Robin;
Leijenaar, Ralph T. H.;
Kocher, Martin;
Lerche, Christoph;
Filss, Christian P.;
Stoffels, Gabriele;
Steidl, Eike;
Hattingen, Elke;
Steinbach, Joachim P.;
Maurer, Gabriele D.;
Heinzel, Alexander;
Galldiks, Norbert;
Mottaghy, Felix M.;
Langen, Karl-Josef;
Lohmann, Philipp

Publication type:

Article

From autoinhibition to inhibition in trans: the Raf-1 regulatory domain inhibits Rok-α kinase activity.

Published in:

Journal of Cell Biology, 2009, v. 187, n. 3, p. 335, doi. 10.1083/jcb.200906178

By:

Niault, Théodora;
Sobczak, Izabela;
Meissl, Katrin;
Weitsman, Gregory;
Piazzolla, Daniela;
Maurer, Gabriele;
Kern, Florian;
Ehrenreiter, Karin;
Hamerl, Matthias;
Moarefi, Ismail;
Leung, Thomas;
Carugo, Oliviero;
Ng, Tony;
Baccarini, Manuela

Publication type:

Article

Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBVmax nor vessel densities correlate between newly diagnosed and progressive glioblastoma.

Published in:

PLoS ONE, 2023, v. 18, n. 2, p. 1, doi. 10.1371/journal.pone.0274400

By:

Steidl, Eike;
Filipski, Katharina;
Hattingen, Elke;
Steinbach, Joachim P.;
Maurer, Gabriele D.

Publication type:

Article

Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide.

Published in:

International Journal of Molecular Sciences, 2019, v. 20, n. 5, p. 1061, doi. 10.3390/ijms20051061

By:

Maurer, Gabriele D.;
Heller, Sonja;
Wanka, Christina;
Rieger, Johannes;
Steinbach, Joachim P.

Publication type:

Article

Gene Suppression of Transketolase-Like Protein 1 (TKTL1) Sensitizes Glioma Cells to Hypoxia and Ionizing Radiation.

Published in:

International Journal of Molecular Sciences, 2018, v. 19, n. 8, p. 2168, doi. 10.3390/ijms19082168

By:

Heller, Sonja;
Maurer, Gabriele D.;
Wanka, Christina;
Hofmann, Ute;
Luger, Anna-Luisa;
Bruns, Ines;
Steinbach, Joachim P.;
Rieger, Johannes

Publication type:

Article

Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 6, p. 1956, doi. 10.1007/s00259-020-05114-0

By:

Steidl, Eike;
Langen, Karl-Josef;
Hmeidan, Sarah Abu;
Polomac, Nenad;
Filss, Christian P.;
Galldiks, Norbert;
Lohmann, Philipp;
Keil, Fee;
Filipski, Katharina;
Mottaghy, Felix M.;
Shah, Nadim Jon;
Steinbach, Joachim P.;
Hattingen, Elke;
Maurer, Gabriele D.

Publication type:

Article

A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis.

Published in:

Nature Communications, 2016, v. 7, n. 12, p. 13781, doi. 10.1038/ncomms13781

By:

Jeric, Ines;
Maurer, Gabriele;
Cavallo, Anna Lina;
Raguz, Josipa;
Desideri, Enrico;
Tarkowski, Bartosz;
Parrini, Matthias;
Fischer, Irmgard;
Zatloukal, Kurt;
Baccarini, Manuela

Publication type:

Article

Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma Patients.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 12, p. 2031, doi. 10.3390/jcm8122031

By:

Zeiner, Pia S.;
Kinzig, Martina;
Divé, Iris;
Maurer, Gabriele D.;
Filipski, Katharina;
Harter, Patrick N.;
Senft, Christian;
Bähr, Oliver;
Hattingen, Elke;
Steinbach, Joachim P.;
Sörgel, Fritz;
Voss, Martin;
Steidl, Eike;
Ronellenfitsch, Michael W.

Publication type:

Article

Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.

Published in:

International Journal of Cancer, 2009, v. 125, n. 4, p. 894, doi. 10.1002/ijc.24462

By:

Buergy, Daniel;
Weber, Theresia;
Maurer, Gabriele D.;
Mudduluru, Giridhar;
Medved, Fabian;
Leupold, Joerg H.;
Brauckhoff, Michael;
Post, Stefan;
Dralle, Henning;
Allgayer, Heike

Publication type:

Article

CAR T-cell-associated secondary malignancies challenge current pharmacovigilance concepts.

Published in:

EMBO Molecular Medicine, 2025, v. 17, n. 2, p. 211, doi. 10.1038/s44321-024-00183-2

By:

Berg, Philipp;
Ruppert-Seipp, Gabriele;
Müller, Susanne;
Maurer, Gabriele D;
Hartmann, Jessica;
Holtick, Udo;
Buchholz, Christian J;
Funk, Markus B

Publication type:

Article

Prognostic Impact of Extracellular Matrix Metalloprotease Inducer.

Published in:

Cancer (0008543X), 2009, v. 115, n. 20, p. 4667, doi. 10.1002/cncr.24516

By:

Buergy, Daniel;
Fuchs, Tina;
Kambakamba, Patryk;
Mudduluru, Giridhar;
Maurer, Gabriele;
Post, Stefan;
Yi Tang;
Nakada, Marian T.;
Li Yan;
Ailgayer, Heike

Publication type:

Article

Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL.

Published in:

Journal of Neurochemistry, 2008, v. 106, n. 6, p. 2436, doi. 10.1111/j.1471-4159.2008.05586.x

By:

Rieger, Johannes;
Lemke, Dieter;
Maurer, Gabriele;
Weiler, Markus;
Frank, Brigitte;
Tabatabai, Ghazaleh;
Weller, Michael;
Wick, Wolfgang

Publication type:

Article

Works by Maurer, Gabriele

Matching Quantitative MRI Parameters with Histological Features of Treatment-Naïve IDH Wild-Type Glioma.

Cetuximab-Mediated Protection from Hypoxia- Induced Cell Death: Implications for Therapy Sequence in Colorectal Cancer.

Influence of pregnancy on glioma patients.

FOXO3a orchestrates glioma cell responses to starvation conditions and promotes hypoxia-induced cell death.

ERGO: A pilot study of ketogenic diet in recurrent glioblastoma.

Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST study.

Real-Time Monitoring in der Psychotherapie -- Methodik und Kasuistik.

Integrin control of the transforming growth factor-[beta] pathway in glioblastoma.

Integrin control of the transforming growth factor-β pathway in glioblastoma.

<sup>18</sup>F-FET PET imaging in differentiating glioma progression from treatment-related changes – a single-center experience.

Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression.

From autoinhibition to inhibition in trans: the Raf-1 regulatory domain inhibits Rok-α kinase activity.

Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBV<sub>max</sub> nor vessel densities correlate between newly diagnosed and progressive glioblastoma.

Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide.

Gene Suppression of Transketolase-Like Protein 1 (TKTL1) Sensitizes Glioma Cells to Hypoxia and Ionizing Radiation.

Sequential implementation of DSC-MR perfusion and dynamic [18F]FET PET allows efficient differentiation of glioma progression from treatment-related changes.

A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis.

Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma Patients.

Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.

CAR T-cell-associated secondary malignancies challenge current pharmacovigilance concepts.

Prognostic Impact of Extracellular Matrix Metalloprotease Inducer.

Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-X<sub>L</sub>.